Explore our certified cold chain containers, hazmat transport vehicles, and specialized temperature-controlled logistics equipment designed for global pharmaceutical, biological, and chemical supply chains.
Air Freight
Priority biological specimen and vaccine transport featuring active temperature tracking, expedited customs clearance, and seamless door-to-door temperature integrity.
Storage & Containment
Heavy-duty reusable and refurbished IBC totes engineered for liquid pharmaceuticals, active ingredients, and hazardous chemical liquid cold preservation.
Global Freight
Comprehensive ocean and air freight forwarder providing multi-zone temperature isolation, bio-specimen handling, and end-to-end regulatory oversight.
Ocean Logistics
High-capacity cold chain container shipping equipped with dual-redundant refrigeration, humidity control, and continuous remote telemetry.
Active Hazmat
Class 9 hazardous lithium-battery powered active cooling transport boxes for critical mRNA vaccines, plasma, and temperature-sensitive biologicals.
DNV Certified
Heavy-duty, offshore-grade thermal and flat rack containers custom-built for extreme ambient conditions and remote mobile laboratory deployment.
Class 3/8/9 Freight
Specialized temperature-regulated road freight, featuring GDP-certified drivers, emergency backup cooling systems, and full regulatory documentation.
Heavy Machinery
Heavy-duty industrial tank transporter with wireless remote control, designed for safe maneuvering of cryogenic liquid nitrogen and bulk vaccine vessels.
The global distribution of biopharmaceuticals, mRNA-based vaccines, viral vector therapies, and biological active pharmaceutical ingredients (APIs) represents one of the most technically demanding disciplines in modern industrial manufacturing and logistics. As an industry-leading OEM/ODM vaccine temperature-controlled transport manufacturer and global exporter, our organization bridges the critical gap between advanced thermodynamic insulation engineering and rigorous international compliance standards (WHO PQS, US FDA 21 CFR Part 11, and EU Good Distribution Practice - GDP).
Our state-of-the-art OEM/ODM manufacturing facilities produce active refrigerated containers, hybrid thermal transport shippers, and passive cryogenic shippers configured for extreme environmental conditions. We collaborate directly with pharmaceutical procurement executives, contract development and manufacturing organizations (CDMOs), and international humanitarian relief organizations to design transport packaging systems optimized for specific thermal profiles:
Engineered for mRNA vaccines requiring strict -80°C to -60°C environments using high-density dry-ice sublimation chambers and liquid nitrogen vapor phase technology.
Utilizing high-latent-heat organic Phase Change Materials (PCM) and solid-state thermoelectric cooling modules to ensure zero freezing spikes for sensitive liquid formulations.
Un3480/UN3481 certified lithium iron phosphate (LiFePO4) power reserves powering micro-compressors with up to 120 hours of continuous active regulation during flight delays.
Operating out of our strategic manufacturing and freight forwarding hubs—positioned adjacent to international airport gateways (such as LAX, AMS, PVG) and deep-water container ports—our integrated service network combines manufacturing prowess with end-to-end logistics execution. We do not simply manufacture shippers; we manage the complex operational ecosystem required to move dangerous goods and temperature-critical payloads globally.
Our internal freight forwarding division specializes in Class 3, 8, and 9 Dangerous Goods (DGR) handling, customs brokerage, Importer Security Filing (ISF), and temperature-monitored ground drayage. Whether shipping via DNV-certified offshore flat-rack containers or custom 30-ton electric tank carriers for bulk raw materials, our clients receive unified accountability across every leg of the supply chain.
The global market for temperature-controlled pharmaceutical logistics is undergoing a paradigm shift driven by technological innovation and evolving regulatory frameworks. B2B procurement managers and supply chain directors must navigate three macro trends when selecting OEM/ODM partners:
Static passive shippers are rapidly being replaced by connected thermal boxes equipped with real-time GPS, shock, tilt, door-open, and ambient temperature telemetry. Multi-sensor IoT loggers broadcast data directly to cloud dashboards, allowing proactive intervention before thermal degradation occurs.
Global pharmaceutical corporations are mandating zero-waste and circular economy initiatives. OEM manufacturers must now provide fully reusable, returnable insulation systems backed by global reverse-logistics programs, reducing carbon footprints by up to 65% per trip.
Customs authorities worldwide are strictly enforcing WHO PQS and IATA CEIV Pharma certifications. Shippers must present rigorous ISTA 7D/7E thermal qualification reports detailing performance against summer and winter ambient temperature profiles.
As a seasoned manufacturer and licensed international freight forwarder, our organization provides unmatched operational security for sensitive bio-pharma shipments:
Key technical considerations for procurement officers, pharmaceutical logistics leads, and distributors.
